Title: Disease modifying therapies for relapsing multiple sclerosis.
Journal: BMJ (Clinical research ed.) 20160822
Title: Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
Journal: Journal of the neurological sciences 20121215
Title: Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Journal: Clinical immunology (Orlando, Fla.) 20121101
Title: Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20121001
Title: Disease-modifying drugs for multiple sclerosis and JC virus expression.
Journal: Journal of neurovirology 20121001
Title: Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort.
Journal: Arquivos de neuro-psiquiatria 20121001
Title: An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.
Journal: Science translational medicine 20120926
Title: Age-related changes in the pattern electroretinogram of normal and glatiramer acetate-immunized rats.
Journal: Investigative ophthalmology & visual science 20120921
Title: Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Journal: The New England journal of medicine 20120920
Title: The 'poison chair' treatment for multiple sclerosis.
Journal: The New England journal of medicine 20120920
Title: Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
Journal: Neurology 20120911
Title: Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Journal: Journal of the neurological sciences 20120815
Title: [Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate].
Journal: Revista de neurologia 20120801
Title: Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20120701
Title: First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.
Journal: Drugs 20120618
Title: Decreased microglial activation in MS patients treated with glatiramer acetate.
Journal: Journal of neurology 20120601
Title: Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response.
Journal: European journal of neurology 20120601
Title: Management of children with multiple sclerosis.
Journal: Paediatric drugs 20120601
Title: Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod.
Journal: Current medical research and opinion 20120501
Title: Immunotherapies in neurologic disorders.
Journal: The Medical clinics of North America 20120501
Title: Spasticity improvement in patients with relapsing-remitting multiple sclerosis switching from interferon-β to glatiramer acetate: the Escala Study.
Journal: Journal of the neurological sciences 20120415
Title: Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20120401
Title: The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally.
Journal: Clinical reviews in allergy & immunology 20120401
Title: Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging 20120401
Title: Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.
Journal: European journal of clinical pharmacology 20120401
Title: Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.
Journal: Journal of neuroimmunology 20120401
Title: Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.
Journal: Expert review of neurotherapeutics 20120401
Title: [2012: Update on diagnosis and treatment of multiple sclerosis].
Journal: Deutsche medizinische Wochenschrift (1946) 20120401
Title: Glatiramer acetate induced hepatotoxicity.
Journal: Current drug safety 20120401
Title: Immunization with A91 peptide or copolymer-1 reduces the production of nitric oxide and inducible nitric oxide synthase gene expression after spinal cord injury.
Journal: Journal of neuroscience research 20120301
Title: Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20120301
Title: Glatiramer acetate reverts stress-induced alterations on adult neurogenesis and behavior. Involvement of Th1/Th2 balance.
Journal: Brain, behavior, and immunity 20120301
Title: Contribution of endermology to improving indurations and panniculitis/lipoatrophy at glatiramer acetate injection site.
Journal: Advances in therapy 20120301
Title: Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20120201
Title: Effect of disease-modifying therapies on brain volume in relapsing-remitting multiple sclerosis: results of a five-year brain MRI study.
Journal: Journal of the neurological sciences 20120115
Title: Adherence to treatment in multiple sclerosis.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101
Title: Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20120101
Title: Comparative long-term preclinical safety evaluation of two glatiramoid compounds (glatiramer Acetate, Copaxone(R), and TV-5010, protiramer) in rats and monkeys.
Journal: Toxicologic pathology 20120101
Title: Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Journal: Pharmacogenomics 20120101
Title: The effectiveness of glatiramer acetate in clinical practice: an observational study.
Journal: Revista de neurologia 20120101
Title: Magnetization transfer imaging of acute black holes in patients on glatiramer acetate.
Journal: Frontiers in bioscience (Elite edition) 20120101
Title: Cost-effectiveness analysis of disease modifiying drugs (interferons and glatiramer acetate) as first line treatments in remitting-relapsing multiple sclerosis patients.
Journal: Journal of medical economics 20120101
Title: Early diagnosis, monitoring, and treatment of optic neuritis.
Journal: The neurologist 20120101
Title: Impact of inflammation on brain volume in multiple sclerosis.
Journal: Archives of neurology 20120101
Title: Benefit-risk analysis of glatiramer acetate for relapsing-remitting and clinically isolated syndrome multiple sclerosis.
Journal: Clinical therapeutics 20120101
Title: Glatiramer acetate anaphylaxis: detection of antibodies and basophil activation test.
Journal: Journal of investigational allergology & clinical immunology 20120101
Title: Quantitative MRI and cerebrospinal fluid inflammatory mediators in Brazilian patients with relapsing-remitting multiple sclerosis before and after treatment with immunomodulators: a longitudinal study.
Journal: Neuroimmunomodulation 20120101
Title: Development of Guillain-Barré syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate.
Journal: Neurologia i neurochirurgia polska 20120101
Title: [Efficacy and tolerability of long-term using of glatimer acetate (copaxone): a 10 year-study in the Moscow Municipal Multiple Sclerosis center].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20120101
Title: Comparison of standard 1.5 T vs. 3 T optimized protocols in patients treated with glatiramer acetate. A serial MRI pilot study.
Journal: International journal of molecular sciences 20120101
Title: Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
Journal: BMC neurology 20120101
Title: Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease.
Journal: Investigative ophthalmology & visual science 20111121
Title: Contact dermatitis induced by glatiramer acetate.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20111101
Title: [Embolia cutis medicamentosa (Nicolau syndrome) after glatiramer acetate injection].
Journal: Actas dermo-sifiliograficas 20111101
Title: Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Journal: Journal of autoimmunity 20111101
Title: Endermology: a treatment for injection-induced lipoatrophy in multiple sclerosis patients treated with sub cutaneous glatiramer acetate.
Journal: Clinical neurology and neurosurgery 20111101
Title: Early onset of natalizumab-related progressive multifocal leukoencephalopathy.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20111101
Title: Persistence with biologic therapies in the Medicare coverage gap.
Journal: The American journal of managed care 20111101
Title: [Multiple sclerosis: current therapies and future perspectives].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20111101
Title: Glatiramer acetate elevates cell production in the mature retinal pigment epithelium.
Journal: Visual neuroscience 20111101
Title: [Expressional changes of Th1 and Th2 cells in retina of a rat glaucoma model vaccinated by Cop-1].
Journal: Zhonghua yi xue za zhi 20111025
Title: Natalizumab for relapsing remitting multiple sclerosis.
Journal: The Cochrane database of systematic reviews 20111005
Title: Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study.
Journal: Journal of neurology 20111001
Title: Glatiramer acetate modulates TNF-α and IL-10 secretion in microglia and promotes their phagocytic activity.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20110901
Title: De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate.
Journal: Journal of neurology 20110901
Title: Glatiramer acetate treatment directly targets CD11b(+)Ly6G(-) monocytes and enhances the suppression of autoreactive T cells in experimental autoimmune encephalomyelitis.
Journal: Scandinavian journal of immunology 20110901
Title: Clinical consequences of MRI activity in treated multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20110901
Title: Glatiramer acetate-specific antibody titres in patients with relapsing / remitting multiple sclerosis and in experimental autoimmune encephalomyelitis.
Journal: Scandinavian journal of immunology 20110901
Title: MS Forum/MS Over the Past 17 Years.
Journal: International MS journal 20110901
Title: Glatiramer acetate (GA), the immunomodulatory drug, inhibits inflammatory mediators and collagen degradation in osteoarthritis (OA) cartilage.
Journal: Osteoarthritis and cartilage 20110901
Title: Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: retrospective claims analysis.
Journal: Advances in therapy 20110901
Title: Health care situation of patients with relapsing-remitting multiple sclerosis receiving immunomodulatory therapy: a retrospective survey of more than 9000 German patients with MS.
Journal: European journal of neurology 20110801
Title: [Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
Journal: Revista de neurologia 20110801
Title: Glatiramer acetate could be a hypothetical therapeutic agent for neuromyelitis optica.
Journal: Medical hypotheses 20110601
Title: Recent insights into the mechanism of action of glatiramer acetate.
Journal: Journal of neuroimmunology 20110601
Title: Use of diagnostic tests and procedures for disease-modifying therapy users and non-disease-modifying therapy users with multiple sclerosis.
Journal: Expert review of neurotherapeutics 20110601
Title: Effects of cohort selection on the results of cost-effectiveness analysis of disease-modifying drugs for relapsing-remitting multiple sclerosis.
Journal: Journal of managed care pharmacy : JMCP 20110601
Title: Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
Journal: Arquivos de neuro-psiquiatria 20110601
Title: The Brazilian database on pregnancy in multiple sclerosis.
Journal: Clinical neurology and neurosurgery 20110501
Title: Texture analysis differentiates persistent and transient T1 black holes at acute onset in multiple sclerosis: a preliminary study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20110501
Title: Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells.
Journal: Journal of neuroimmunology 20110501
Title: Beneficial effect of glatiramer acetate treatment on syndecan-1 expression in dextran sodium sulfate colitis.
Journal: The Journal of pharmacology and experimental therapeutics 20110501
Title: Interferon-β but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: a clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs.
Journal: Journal of neuroimmunology 20110501
Title: Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
Journal: CNS drugs 20110501
Title: Adherence to multiple sclerosis disease-modifying therapies in Ontario is low.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20110501
Title: Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies.
Journal: The American journal of managed care 20110501
Title: Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis.
Journal: Journal of the neurological sciences 20110415
Title: Interferon β-1b and glatiramer acetate effects on permanent black hole evolution.
Journal: Neurology 20110405
Title: Population structure and HLA DRB1 1501 in the response of subjects with multiple sclerosis to first-line treatments.
Journal: Journal of neuroimmunology 20110401
Title: [Partial adrenocorticotropin hormone deficiency associated with multiple sclerosis].
Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20110401
Title: A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.
Journal: Journal of neurology 20110301
Title: Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate.
Journal: Journal of neuroimmunology 20110301
Title: Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy.
Journal: Pharmacogenomics 20110301
Title: Glatiramer acetate treatment of multiple sclerosis: an immunological perspective.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20110215
Title: The therapeutic equivalence of complex drugs.
Journal: Regulatory toxicology and pharmacology : RTP 20110201
Title: Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.
Journal: Medical hypotheses 20110201
Title: Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate.
Journal: Human immunology 20110201
Title: Qualitative spectral OCT/SLO analysis of drusen change in dry age-related macular degeneration patients treated with Copaxone.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110201
Title: [Current treatment of multiple sclerosis].
Journal: Lege artis medicinae : uj magyar orvosi hirmondo 20110201
Title: The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis.
Journal: European journal of neurology 20110101
Title: Glatiramer acetate for treatment of MS: regulatory B cells join the cast of players.
Journal: Experimental neurology 20110101
Title: Adherence to disease-modifying therapies in spanish patients with relapsing multiple sclerosis: two-year interim results of the global adherence project.
Journal: European neurology 20110101
Title: Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.
Journal: Annals of neurology 20110101
Title: Patterns of TH1/TH2 cytokines predict clinical response in multiple sclerosis patients treated with glatiramer acetate.
Journal: European neurology 20110101
Title: Current disease-modifying treatment of multiple sclerosis.
Journal: The Mount Sinai journal of medicine, New York 20110101
Title: [Rare and clinically relevant adverse reactions following subcutaneous administration of glatiramer acetate].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101
Title: Drug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study).
Journal: BMC neurology 20110101
Title: Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon-beta and glatiramer acetate.
Journal: European neurology 20110101
Title: The relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate.
Journal: Journal of medical economics 20110101
Title: Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Journal: PloS one 20110101
Title: Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.
Journal: PloS one 20110101
Title: Glatiramer acetate treatment increases stability of spinal synapses and down regulates MHC I during the course of EAE.
Journal: International journal of biological sciences 20110101
Title: The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study.
Journal: BMC neurology 20110101
Title: Anaphylactic reaction after injection of glatiramer acetate (Copaxone®) in patients with relapsing-remitting multiple sclerosis.
Journal: European neurology 20110101
Title: Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE.
Journal: PloS one 20110101
Title: [Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy].
Journal: Molekuliarnaia biologiia 20110101
Title: [State of antioxidant system in patients with multiple sclerosis during therapy].
Journal: Biomeditsinskaia khimiia 20110101
Title: The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice.
Journal: Journal of neuroimmunology 20101215
Title: Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.
Journal: Journal of neurology 20101201
Title: A method for evaluating treatment switching criteria in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20101201
Title: Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20101201
Title: Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death.
Journal: The American journal of pathology 20101201
Title: Translational research in neurology and neuroscience 2010: multiple sclerosis.
Journal: Archives of neurology 20101101
Title: Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series.
Journal: CNS drugs 20101101
Title: Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative study.
Journal: Journal of neurology 20101101
Title: Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2.
Journal: Journal of neuroimmunology 20101008
Title: Pharmacoeconomic considerations in the treatment of multiple sclerosis.
Journal: Drugs 20100910
Title: Therapy of multiple sclerosis in children and adolescents.
Journal: Clinical neurology and neurosurgery 20100901
Title: Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20100901
Title: The identity problem.
Journal: Nature biotechnology 20100901
Title: A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.
Journal: Archives of neurology 20100901
Title: Reversible alopecia associated with glatiramer acetate.
Journal: Archives of neurology 20100901
Title: [Global adherence project to disease-modifying therapies in patients with relapsing multiple sclerosis: 2-year interim results].
Journal: Neurologia (Barcelona, Spain) 20100901
Title: Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
Journal: Journal of neuroimmunology 20100825
Title: Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
Journal: Drugs 20100820
Title: Modified protocol for desensitization to glatiramer acetate.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20100801
Title: Generalized skin drug eruption to natalizumab in a patient with multiple sclerosis.
Journal: Dermatology online journal 20100615
Title: [Glatiramer acetate in patients with clinically isolated multiple sclerosis syndrome: PreCISe study].
Journal: Der Internist 20100601
Title: Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20100601
Title: Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study.
Journal: Clinical therapeutics 20100601
Title: Glatiramer acetate for multiple sclerosis.
Journal: The Cochrane database of systematic reviews 20100512
Title: Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update.
Journal: Expert opinion on drug metabolism & toxicology 20100501
Title: [Diagnosis and therapy in multiple sclerosis].
Journal: Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20100501
Title: Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis--a longitudinal MRI study.
Journal: Brain research 20100414
Title: Novel anti-inflammatory and neuroprotective agents for Parkinson's disease.
Journal: CNS & neurological disorders drug targets 20100401
Title: Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.
Journal: Clinical immunology (Orlando, Fla.) 20100401
Title: Improved muscle strength and mobility in the dy(2J)/dy(2J) mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate.
Journal: Neuromuscular disorders : NMD 20100401
Title: Glatiramer acetate: successful desensitization for treatment of multiple sclerosis.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20100401
Title: A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective.
Journal: Clinical therapeutics 20100401
Title: The double-edged sword of autoimmunity: lessons from multiple sclerosis.
Journal: Toxins 20100401
Title: Long-term treatment of multiple sclerosis with glatiramer acetate: natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy.
Journal: Journal of neuroimmunology 20100330
Title: [Pharmacological treatment of multiple sclerosis].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20100311
Title: Persistence and adherence to disease modifying drugs among patients with multiple sclerosis.
Journal: Current medical research and opinion 20100301
Title: Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20100301
Title: Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.
Journal: Journal of neuroimmunology 20100226
Title: Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20100201
Title: Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20100201
Title: Glatiramer acetate immune system augmentation for peripheral nerve regeneration in rat crushed sciatic nerve model.
Journal: The Journal of bone and joint surgery. American volume 20100201
Title: Effect of oral antihistamine on local injection site reactions with self-administered glatiramer acetate.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20100201
Title: The mechanism of action of glatiramer acetate treatment in multiple sclerosis.
Journal: Neurology 20100105
Title: [Immunomodulatory treatments for multiple sclerosis: lessons from direct comparative studies].
Journal: Revue neurologique 20100101
Title: Effects of methylprednisolone and glatiramer acetate on nitric oxide formation of cytokine-stimulated cells from the rat oligodendroglial cell line OLN-93.
Journal: Neuroimmunomodulation 20100101
Title: B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Journal: Experimental neurology 20100101
Title: [Update on current care guidelines: diagnostics, treatment and rehabilitation of multiple sclerosis].
Journal: Duodecim; laaketieteellinen aikakauskirja 20100101
Title: Glatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts.
Journal: Journal of medical economics 20100101
Title: Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report.
Journal: BMC neurology 20100101
Title: Medication adherence with disease modifying treatments for multiple sclerosis among US employees.
Journal: Journal of medical economics 20100101
Title: Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
Journal: Health and quality of life outcomes 20100101
Title: Allergy workup in immediate-type local reactions to glatiramer acetate.
Journal: Journal of investigational allergology & clinical immunology 20100101
Title: [Effect of glatiramer acetate (copaxone) on the structure and functions of the thyroid gland in patients with multiple sclerosis].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
Title: New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate.
Journal: Journal of neurology, neurosurgery, and psychiatry 20091201
Title: Restoring immune suppression in the multiple sclerosis brain.
Journal: Progress in neurobiology 20091201
Title: Disease-modifying agents in the treatment of multiple sclerosis: a review of long-term outcomes.
Journal: CNS & neurological disorders drug targets 20091201
Title: Do interferon beta-1b and glatiramer acetate grow brain?
Journal: The Lancet. Neurology 20091201
Title: Health and quality of life in patients with relapsing multiple sclerosis: making the intangible tangible.
Journal: Journal of the neurological sciences 20091201
Title: Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
Journal: Journal of the neurological sciences 20091201
Title: Early treatment: PreCISe-ly what the patient needs.
Journal: Journal of the neurological sciences 20091201
Title: Current therapeutic recommendations in multiple sclerosis.
Journal: Journal of the neurological sciences 20091201
Title: Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis.
Journal: Journal of neuroimmunology 20091130
Title: Glatiramer acetate treatment in PPMS: why males appear to respond favorably.
Journal: Journal of the neurological sciences 20091115
Title: A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
Journal: Neurology 20091110
Title: Cutaneous adverse events related to glatiramer acetate injection (copolymer-1, Copaxone).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 20091101
Title: Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20091101
Title: Serum levels of CXCL13 are elevated in active multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20091101
Title: Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
Journal: Current opinion in ophthalmology 20091101
Title: Severe liver dysfunction in a patient with multiple sclerosis: the guilty party is not always the disease-modifying therapy.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20091101
Title: Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England) 20091031
Title: Inhibition of experimental autoimmune uveitis by amino acid copolymers.
Journal: Journal of neuroimmunology 20091030
Title: Transplanted myogenic progenitor cells express neuronal markers in the CNS and ameliorate disease in experimental autoimmune encephalomyelitis.
Journal: Journal of neuroimmunology 20091030
Title: 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
Journal: The Lancet. Neurology 20091001
Title: Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20091001
Title: Treatment of multiple sclerosis: role of natalizumab.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20091001
Title: The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?
Journal: Neurology 20090922
Title: Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study.
Journal: Journal of the neurological sciences 20090915
Title: Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20090901
Title: Comparing the cost-effectiveness of disease-modifying drugs for the first-line treatment of relapsing-remitting multiple sclerosis.
Journal: Journal of managed care pharmacy : JMCP 20090901
Title: [Glatiramer acetate in interferon beta non respondent relapsing-remitting multiple sclerosis].
Journal: Neurologia (Barcelona, Spain) 20090901
Title: Adherence of adolescents to multiple sclerosis disease-modifying therapy.
Journal: Pediatric neurology 20090801
Title: Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20090801
Title: Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on data a Balkan country in socioeconomic transition.
Journal: Vojnosanitetski pregled 20090701
Title: Cyclophosphamide therapy in pediatric multiple sclerosis.
Journal: Neurology 20090616
Title: Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
Journal: Neurology 20090609
Title: Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20090601
Title: Benefits of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis.
Journal: Expert review of pharmacoeconomics & outcomes research 20090601
Title: Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes.
Journal: Cell research 20090501
Title: Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis.
Journal: Advances in therapy 20090501
Title: Suppression of ongoing experimental allergic encephalomyelitis in DA rats by novel peptide drug, structural part of human myelin basic protein 46-62.
Journal: Autoimmunity 20090501
Title: Progressive lipoatrophy after cessation of glatiramer acetate injections: a case report.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20090401
Title: Modulation of natural killer cell cytotoxicity and cytokine release by the drug glatiramer acetate.
Journal: Cellular and molecular life sciences : CMLS 20090401
Title: Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.
Journal: Neurology 20090317
Title: GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
Journal: Neurology 20090303
Title: Ameliorative effect of PN-277 on laser-induced retinal damage.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20090301
Title: Favorable effect of immunomodulator therapy on bone mineral density in multiple sclerosis.
Journal: Irish journal of medical science 20090301
Title: Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment.
Journal: European journal of neurology 20090301
Title: Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis.
Journal: European journal of neurology 20090301
Title: The glatiramoid class of immunomodulator drugs.
Journal: Expert opinion on pharmacotherapy 20090301
Title: [Therapy of multiple sclerosis].
Journal: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20090301
Title: Glatiramer acetate positively influences spinal motoneuron survival and synaptic plasticity after ventral root avulsion.
Journal: Neuroscience letters 20090213
Title: The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20090201
Title: Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis.
Journal: European journal of neurology 20090201
Title: Link of the mechanisms of action of glatiramer acetate to its long-term clinical data.
Journal: Journal of the neurological sciences 20090201
Title: Prospects of repair in multiple sclerosis.
Journal: Journal of the neurological sciences 20090201
Title: Lessons from randomised direct comparative trials.
Journal: Journal of the neurological sciences 20090201
Title: What can be learned from open direct comparative trials in multiple sclerosis?
Journal: Journal of the neurological sciences 20090201
Title: Implications of neutralising antibodies on therapeutic efficacy.
Journal: Journal of the neurological sciences 20090201
Title: Multiple sclerosis beyond EDSS: depression and fatigue.
Journal: Journal of the neurological sciences 20090201
Title: Concepts of induction and escalation therapy in multiple sclerosis.
Journal: Journal of the neurological sciences 20090201
Title: Immunosuppression followed by immunomodulation.
Journal: Journal of the neurological sciences 20090201
Title: New options for early treatment of multiple sclerosis.
Journal: Journal of the neurological sciences 20090201
Title: The immunomodulator glatiramer acetate influences spinal motoneuron plasticity during the course of multiple sclerosis in an animal model.
Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20090201
Title: [Neuroprotection in Parkinson's disease and other neurodegenerative disorders: preclinical and clinical findings].
Journal: Ideggyogyaszati szemle 20090130
Title: Glatiramer acetate: a novel therapeutic approach in Crohn's disease?
Journal: Inflammatory bowel diseases 20090101
Title: Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20090101
Title: State of the cervical section of the spinal cord in patients with remitting multiple sclerosis during immunomodulatory treatment.
Journal: Neuroscience and behavioral physiology 20090101
Title: The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.
Journal: Neuroscience and behavioral physiology 20090101
Title: The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.
Journal: BMC neurology 20090101
Title: Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
Journal: Malaria journal 20090101
Title: Interferon beta and glatiramer acetate induce proliferation of Schwann cells in vitro.
Journal: Acta neurobiologiae experimentalis 20090101
Title: Necrotizing skin lesions with involvement of muscle tissue after subcutaneous injection of glatiramer acetate.
Journal: European journal of dermatology : EJD 20090101
Title: Cost-effectiveness of disease-modifying therapies in the management of multiple sclerosis for the Medicare population.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101
Title: Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
Journal: Neuroimmunomodulation 20090101
Title: Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis.
Journal: Applied health economics and health policy 20090101
Title: Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis.
Journal: Disease markers 20090101
Title: Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial.
Journal: Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
Title: Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.
Journal: BMJ (Clinical research ed.) 20090101
Title: Recent developments in multiple sclerosis therapeutics.
Journal: BMC medicine 20090101
Title: [Combined therapy of aggressive remitted multiple sclerosis with mitoxantrone in combination with copaxone].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101
Title: The implications of immunogenicity for protein-based multiple sclerosis therapies.
Journal: Journal of the neurological sciences 20081215
Title: Early interferon beta treatment in multiple sclerosis: nursing care implications of the BENEFIT study.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20081201
Title: Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
Journal: Neurology 20081125
Title: Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis.
Journal: Journal of neuroimmunology 20081115
Title: The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.
Journal: Clinical neurology and neurosurgery 20081101
Title: Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies.
Journal: Clinical neurology and neurosurgery 20081101
Title: The therapeutic effect of TV-5010 in a murine model of inflammatory bowel disease -- Dextran induced colitis.
Journal: International immunopharmacology 20081101
Title: [Long-term effects of glatiramer acetate in multiple sclerosis].
Journal: Revue neurologique 20081101
Title: Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.
Journal: Current eye research 20081101
Title: Predictors of the location of multiple sclerosis relapse.
Journal: Journal of neurology, neurosurgery, and psychiatry 20081001
Title: CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20081001
Title: Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
Journal: International immunology 20081001
Title: Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial.
Journal: The Lancet. Neurology 20081001
Title: Glatiramer acetate-associated, CD30+, primary, cutaneous, anaplastic large-cell lymphoma.
Journal: Archives of neurology 20081001
Title: Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
Journal: Journal of neurology 20081001
Title: Impact of co-prescribed glatiramer acetate and antihistamine therapy on the likelihood of relapse among patients with multiple sclerosis.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20081001
Title: Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.
Journal: Journal of neurology 20081001
Title: Clinical markers of therapeutic response to disease modifying drugs.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20080901
Title: Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20080901
Title: [Protection of autoimmunity induced by copolymer-1 on optic nerve: experiment with rat glaucoma models].
Journal: Zhonghua yi xue za zhi 20080805
Title: Impact of warm compresses on local injection-site reactions with self-administered glatiramer acetate.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20080801
Title: Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Journal: Journal of neuroimmunology 20080715
Title: Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.
Journal: Neurology 20080708
Title: Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis.
Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging 20080701
Title: Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone).
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20080701
Title: Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20080701
Title: Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients.
Journal: Advances in therapy 20080701
Title: Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20080601
Title: Effective multiple sclerosis management through improved patient assessment.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20080601
Title: Pharmacologic management of multiple sclerosis.
Journal: Urologic nursing 20080601
Title: Comparative studies of glatiramer acetate and interferon beta.
Journal: International MS journal 20080601
Title: IL-12-impaired and IL-12-secreting dendritic cells produce IL-23 upon CD154 restimulation.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20080515
Title: Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20080501
Title: Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
Journal: The Cochrane database of systematic reviews 20080416
Title: Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20080401
Title: T cells in amyotrophic lateral sclerosis.
Journal: European journal of neurology 20080401
Title: Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of two cases.
Journal: Journal of cutaneous pathology 20080401
Title: Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing-remitting multiple sclerosis in Argentina.
Journal: European journal of neurology 20080401
Title: Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20080401
Title: Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis.
Journal: Journal of the neurological sciences 20080315
Title: Structural insight into the function of myelin basic protein as a ligand for integrin alpha M beta 2.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20080315
Title: Immunomodulation with glatiramer acetate prevents long-term inflammatory pain.
Journal: The International journal of neuroscience 20080301
Title: Glatiramer acetate: evidence for a dual mechanism of action.
Journal: Journal of neurology 20080301
Title: Rationale for early intervention with immunomodulatory treatments.
Journal: Journal of neurology 20080301
Title: Combination therapies in multiple sclerosis.
Journal: Journal of neurology 20080301
Title: Functional efficacy of glatiramer acetate treatment for laser-induced retinal damage in rats.
Journal: Lasers in surgery and medicine 20080301
Title: A case of multiple sclerosis with atypical onset associated with autoimmune hepatitis and silent coeliac disease.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20080201
Title: Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis.
Journal: Glia 20080115
Title: Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.
Journal: Journal of neurology, neurosurgery, and psychiatry 20080101
Title: Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20080101
Title: Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20080101
Title: Benign multiple sclerosis: a distinct clinical entity with therapeutic implications.
Journal: Current topics in microbiology and immunology 20080101
Title: Cost-effectiveness analyses of natalizumab (Tysabri) compared with other disease-modifying therapies for people with highly active relapsing-remitting multiple sclerosis in the UK.
Journal: PharmacoEconomics 20080101
Title: Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone.
Journal: Digestion 20080101
Title: Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis.
Journal: Health and quality of life outcomes 20080101
Title: Application of glatiramer acetate to neurodegenerative diseases beyond multiple sclerosis: the need for disease-specific approaches.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20080101
Title: Concomitant radiochemotherapy in a patient with multiple sclerosis and glioblastoma.
Journal: Clinical neuropathology 20080101
Title: Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.
Journal: Health and quality of life outcomes 20080101
Title: An urticarial vasculitis case induced by glatiramer acetate.
Journal: The Journal of dermatological treatment 20080101
Title: Neurogenesis and neuroprotection in the CNS--fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders.
Journal: Molecular neurobiology 20071201
Title: Embolia cutis medicamentosa following subcutaneous injection of glatiramer acetate.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20071201
Title: T cell independent mechanism for copolymer-1-induced neuroprotection.
Journal: European journal of immunology 20071101
Title: A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate.
Journal: European journal of neurology 20071101
Title: The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
Journal: Immunology letters 20071015
Title: CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.
Journal: Clinical immunology (Orlando, Fla.) 20071001
Title: Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20071001
Title: Mechanism of action of glatiramer acetate in treatment of multiple sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20071001
Title: Copolymer-1 (Cop-1) improves neurological recovery after middle cerebral artery occlusion in rats.
Journal: Neuroscience letters 20070925
Title: [Recent advances in the pathogenesis and immunotherapy of multiple sclerosis].
Journal: Der Nervenarzt 20070901
Title: White matter alteration in a patient with Graves' disease.
Journal: Journal of child neurology 20070901
Title: Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.
Journal: Journal of the neurological sciences 20070815
Title: Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS.
Journal: Experimental neurology 20070801
Title: Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers.
Journal: Pharmacogenetics and genomics 20070801
Title: Glatiramer acetate: mechanisms of action in multiple sclerosis.
Journal: Autoimmunity reviews 20070801
Title: Glatiramer acetate immunization induces specific antibody and cytokine responses in ALS patients.
Journal: Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20070801
Title: Combination therapy with interferon-beta and glatiramer acetate in multiple sclerosis.
Journal: Acta neurologica Scandinavica 20070801
Title: Copaxone interferes with the PrP Sc-GAG interaction.
Journal: European journal of neurology 20070801
Title: Type II monocytes modulate T cell-mediated central nervous system autoimmune disease.
Journal: Nature medicine 20070801
Title: Erythema nodosum and glatiramer acetate treatment in relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20070801
Title: Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.
Journal: World journal of gastroenterology 20070714
Title: Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20070701
Title: Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model.
Journal: The European journal of neuroscience 20070701
Title: Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis.
Journal: Journal of neurology 20070601
Title: Treatment and treatment trials in multiple sclerosis.
Journal: Current opinion in neurology 20070601
Title: Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.
Journal: European journal of neurology 20070601
Title: Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20070601
Title: Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
Journal: Current medical research and opinion 20070601
Title: Immunomodulating drugs in multiple sclerosis: compliance, satisfaction and adverse effects evaluation in a German multiple sclerosis population.
Journal: Current medical research and opinion 20070601
Title: Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20070501
Title: Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial.
Journal: Journal of the neurological sciences 20070415
Title: Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Journal: Neurobiology of disease 20070401
Title: Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis.
Journal: Journal of neuroimmunology 20070401
Title: Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on long-term clinical data.
Journal: Journal of managed care pharmacy : JMCP 20070401
Title: Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20070401
Title: Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS.
Journal: Neurology 20070320
Title: Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.
Journal: American journal of physiology. Gastrointestinal and liver physiology 20070201
Title: CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Journal: Journal of neuroimmunology 20070201
Title: Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
Journal: Medical hypotheses 20070101
Title: Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
Journal: Annals of neurology 20070101
Title: Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20070101
Title: Immunomodulatory treatment of multiple sclerosis in Norway.
Journal: Acta neurologica Scandinavica. Supplementum 20070101
Title: Glatiramer acetate: mechanisms of action in multiple sclerosis.
Journal: International review of neurobiology 20070101
Title: Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
Journal: Medical hypotheses 20070101
Title: Glatiramer acetate in multiple sclerosis: a review.
Journal: CNS drug reviews 20070101
Title: Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007.
Journal: Journal of managed care pharmacy : JMCP 20070101
Title: Glatiramer acetate-specific human CD8(+) T cells: increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment.
Journal: Journal of neuroimmunology 20061201
Title: Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: a clinicopathologic and immunohistochemical study.
Journal: Journal of the American Academy of Dermatology 20061201
Title: Glatiramer acetate therapy for multiple sclerosis: a review.
Journal: Expert opinion on drug metabolism & toxicology 20061201
Title: [Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)].
Journal: Der Nervenarzt 20061201
Title: [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
Journal: Ideggyogyaszati szemle 20061120
Title: Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis.
Journal: Journal of neuroimmunology 20061101
Title: Effect of glatiramer acetate (Copaxone) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: a longitudinal study.
Journal: Neuroscience letters 20061009
Title: Necrotising cutaneous lesions as a side effect of glatiramer acetate.
Journal: Journal of neurology 20061001
Title: Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study.
Journal: The American journal of pathology 20061001
Title: Disease-modifying drugs for multiple sclerosis: current and future aspects.
Journal: Expert opinion on pharmacotherapy 20061001
Title: CD28-CD57+ T cells predominate in CD8 responses to glatiramer acetate.
Journal: Journal of neuroimmunology 20060901
Title: Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis.
Journal: Journal of neurology 20060901
Title: Glatiramer in the treatment of multiple sclerosis.
Journal: International journal of nanomedicine 20060901
Title: During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4.
Journal: Journal of neuroimmunology 20060801
Title: Interferon treatment may trigger primary headaches in multiple sclerosis patients.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20060801
Title: Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Journal: The Journal of pharmacology and experimental therapeutics 20060701
Title: Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.
Journal: Acta neurologica Scandinavica 20060601
Title: Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20060601
Title: A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20060601
Title: A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy.
Journal: American journal of ophthalmology 20060601
Title: [Significance of neutralizing antibodies to immunomodulatory therapy and their laboratory analysis in multiple sclerosis].
Journal: Ideggyogyaszati szemle 20060520
Title: Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis.
Journal: Brain : a journal of neurology 20060501
Title: Atorvastatin and glatiramer acetate: new hope in MS?
Journal: The Lancet. Neurology 20060501
Title: Clinical course after change of immunomodulating therapy in relapsing-remitting multiple sclerosis.
Journal: European journal of neurology 20060501
Title: Randomized controlled phase II trial of glatiramer acetate in ALS.
Journal: Neurology 20060411
Title: Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.
Journal: The Journal of clinical investigation 20060403
Title: Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Journal: International immunology 20060401
Title: Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study.
Journal: The Lancet. Neurology 20060301
Title: Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients.
Journal: Journal of neurology 20060201
Title: Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis.
Journal: Clinical and experimental immunology 20060201
Title: Relapsing MS patients' experiences with glatiramer acetate treatment: a phenomenological study.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20060201
Title: The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS.
Journal: Neurology 20060124
Title: Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking.
Journal: Clinical immunology (Orlando, Fla.) 20060101
Title: The use of glatiramer acetate in the treatment of multiple sclerosis.
Journal: Advances in neurology 20060101
Title: Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease.
Journal: Cleveland Clinic journal of medicine 20060101
Title: Immunomodulatory vaccines against autoimmune diseases.
Journal: Rejuvenation research 20060101
Title: Quality of life for veterans with multiple sclerosis on disease-modifying agents: Relationship to disability.
Journal: Journal of rehabilitation research and development 20060101
Title: Effect of immunomodulatory therapy and other factors on employment loss time in multiple sclerosis.
Journal: Work (Reading, Mass.) 20060101
Title: Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis.
Journal: Acta haematologica 20060101
Title: [The results of longitudinal use of copaxone and betaferon in Moscow Multiple Sclerosis Center: issues of efficacy and adherence to therapy].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20060101
Title: [A comparative analysis of rebif 22-mcg and copaxone efficacy in multiple sclerosis].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20060101
Title: [The 1188 A/C ILI2B gene polymorphism in patients with multiple sclerosis and in healthy subjects of Tomsk region].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20060101
Title: Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20051201
Title: Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20051201
Title: A post-marketing study on immunomodulating treatments for relapsing-remitting multiple sclerosis in Lombardia: preliminary results.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20051201
Title: Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20051201
Title: Induction versus escalation therapy.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20051201
Title: Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
Journal: Trends in immunology 20051101
Title: Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis.
Journal: European journal of neurology 20051101
Title: Hass J, Firzlaff M (2005). Twenty-four-month comparison of immunomodulatory treatments--a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone). European Journal of Neurology 12:425-431.
Journal: European journal of neurology 20051101
Title: Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate.
Journal: Journal of neuroimmunology 20051001
Title: The efficacy of glatiramer acetate in beta-interferon-intolerant MS patients.
Journal: Acta neurologica Scandinavica 20051001
Title: Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20050907
Title: Psychosis as a possible side-effect of treatment with glatiramer acetate.
Journal: The international journal of neuropsychopharmacology 20050901
Title: Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease.
Journal: The Journal of clinical investigation 20050901
Title: Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action.
Journal: The Lancet. Neurology 20050901
Title: Diagnosis and disease modifying treatments in multiple sclerosis.
Journal: Postgraduate medical journal 20050901
Title: Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months.
Journal: Arquivos de neuro-psiquiatria 20050901
Title: The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20050801
Title: Neurodegeneration and clinical relevance for early treatment in multiple sclerosis.
Journal: International MS journal 20050801
Title: [Multiple sclerosis--update].
Journal: Praxis 20050727
Title: Glatiramer acetate in multiple sclerosis.
Journal: Expert review of neurotherapeutics 20050701
Title: Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy.
Journal: Journal of the neurological sciences 20050615
Title: Can glatiramer acetate reduce brain atrophy development in multiple sclerosis?
Journal: Journal of the neurological sciences 20050615
Title: Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
Journal: Journal of the neurological sciences 20050615
Title: Twenty-four-month comparison of immunomodulatory treatments - a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone).
Journal: European journal of neurology 20050601
Title: Glatiramer acetate and interferon beta-1a: a patient's view.
Journal: The Lancet. Neurology 20050601
Title: Glatiramer acetate therapy: the plot thickens.
Journal: Archives of neurology 20050601
Title: Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy.
Journal: Archives of neurology 20050601
Title: Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20050601
Title: Long-term follow up of glatiramer acetate compassionate use in Belgium.
Journal: Acta neurologica Belgica 20050601
Title: A practical approach to immunomodulatory therapy for multiple sclerosis.
Journal: Physical medicine and rehabilitation clinics of North America 20050501
Title: Severe anaphylactic reaction to glatiramer acetate with specific IgE.
Journal: Neurology 20050426
Title: Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20050401
Title: Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat.
Journal: Investigative ophthalmology & visual science 20050301
Title: Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1.
Journal: Journal of autoimmunity 20050301
Title: Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20050216
Title: Glatiramer acetate in the treatment of multiple sclerosis.
Journal: Neurologic clinics 20050201
Title: Evidence for use of glatiramer acetate in multiple sclerosis.
Journal: The Lancet. Neurology 20050201
Title: Evidence for use of glatiramer acetate in multiple sclerosis.
Journal: The Lancet. Neurology 20050201
Title: Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis.
Journal: Inflammatory bowel diseases 20050201
Title: Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.
Journal: Breast cancer research and treatment 20050201
Title: Additive effect of the combination of glatiramer acetate and minocycline in a model of MS.
Journal: Journal of neuroimmunology 20050101
Title: Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection.
Journal: International immunopharmacology 20050101
Title: Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data.
Journal: Acta neurologica Scandinavica 20050101
Title: [3-year results of clinical and immunological monitoring of patients with multiple sclerosis treated by copaxone].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101
Title: Factors leading patients to discontinue multiple sclerosis therapies.
Journal: Journal of the American Pharmacists Association : JAPhA 20050101
Title: Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20050101
Title: CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone).
Journal: Folia neuropathologica 20050101
Title: Mechanism of action of mitoxantrone.
Journal: Neurology 20041228
Title: Current approved options for treating patients with multiple sclerosis.
Journal: Neurology 20041228
Title: Strategies for managing the side effects of treatments for multiple sclerosis.
Journal: Neurology 20041214
Title: Neutralizing antibodies to disease-modifying agents in the treatment of multiple sclerosis.
Journal: Neurology 20041214
Title: Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
Journal: Annals of the New York Academy of Sciences 20041201
Title: Multiple sclerosis.
Journal: Clinical evidence 20041201
Title: [Immunomodulatory therapy in multiple sclerosis].
Journal: Ideggyogyaszati szemle 20041120
Title: Lack of evidence for use of glatiramer acetate in multiple sclerosis.
Journal: The Lancet. Neurology 20041101
Title: Pharmacoeconomic considerations of multiple sclerosis therapy with the new disease-modifying agents.
Journal: Expert opinion on pharmacotherapy 20041001
Title: What do we know about the mechanism of action of disease-modifying treatments in MS?
Journal: Journal of neurology 20040901
Title: Inhibition of TNF-alpha production in THP-1 macrophages by glatiramer acetate does not alter their susceptibility to infection by Listeria monocytogenes and does not impair the efficacy of ampicillin or moxifloxacin against intracellular bacteria.
Journal: The Journal of antimicrobial chemotherapy 20040701
Title: The effect of immunomodulatory treatment on multiple sclerosis fatigue.
Journal: Journal of neurology, neurosurgery, and psychiatry 20040701
Title: Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.
Journal: Journal of neuroimmunology 20040701
Title: Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo.
Journal: Brain : a journal of neurology 20040601
Title: Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20040601
Title: Health outcomes in multiple sclerosis.
Journal: Current opinion in neurology 20040601
Title: Non-specific immunosuppressants in the treatment of multiple sclerosis.
Journal: Clinical neurology and neurosurgery 20040601
Title: Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis.
Journal: Health technology assessment (Winchester, England) 20040601
Title: The PROMiSe trial: baseline data review and progress report.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20040601
Title: On the horizon: possible neuroprotective role for glatiramer acetate.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20040601
Title: A prospective study of adherence to glatiramer acetate in individuals with multiple sclerosis.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20040601
Title: Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management.
Journal: Journal of managed care pharmacy : JMCP 20040601
Title: [The effect of copolymer-1 on the apoptosis and the IL-6R expression of the retinal ganglion cells in chronic elevated intraocular pressure rat model].
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20040501
Title: Disease-modifying drugs for the early treatment of multiple sclerosis.
Journal: Expert review of neurotherapeutics 20040501
Title: Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis.
Journal: Neurology 20040427
Title: Glatiramer acetate for the treatment of multiple sclerosis.
Journal: Expert opinion on pharmacotherapy 20040401
Title: Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate.
Journal: Journal of neuroimmunology 20040301
Title: Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs.
Journal: Journal of clinical immunology 20040301
Title: [Multiple sclerosis (MS), an inflammatory or degenerative disease?].
Journal: Presse medicale (Paris, France : 1983) 20040214
Title: Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20040201
Title: Peptidic complex mixtures as therapeutic agents in CNS autoimmunity.
Journal: Molecular immunology 20040201
Title: Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20040201
Title: Therapy with glatiramer acetate for multiple sclerosis.
Journal: The Cochrane database of systematic reviews 20040101
Title: Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosis.
Journal: Advances in experimental medicine and biology 20040101
Title: The cost of multiple sclerosis and the cost effectiveness of disease-modifying agents in its treatment.
Journal: CNS drugs 20040101
Title: Mycophenolate mofetil in multiple sclerosis.
Journal: Clinical neuropharmacology 20040101
Title: [Multiple sclerosis in children and adolescents: history and current experience of immunomodulating treatment].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101
Title: Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20040101
Title: Localized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate (Copaxone) injection for the treatment of multiple sclerosis.
Journal: American journal of clinical dermatology 20040101
Title: Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis.
Journal: Brain : a journal of neurology 20031201
Title: Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20031201
Title: Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20031201
Title: Depressive symptoms in a treated multiple sclerosis cohort.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20031201
Title: Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis.
Journal: Journal of neuroimmunology 20031101
Title: A retrospective, observational study comparing the four available immunomodulatory treatments for relapsing-remitting multiple sclerosis.
Journal: European journal of neurology 20031101
Title: Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis.
Journal: Neuroscience research 20031001
Title: Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20031001
Title: Glatiramer acetate (Copaxone) regulates nitric oxide and related cytokine secretion in experimental autoimmune encephalomyelitis.
Journal: Immunology letters 20030908
Title: Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis.
Journal: Clinical and experimental immunology 20030901
Title: Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20030801
Title: [Newer disease--modifying drugs: glatiramer acetate and mitoxantrone].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030801
Title: Modulation effects of human immature and mature dendritic cells on glatiramer acetate specific T cell lines in vitro.
Journal: Zhongguo shi yan xue ye xue za zhi 20030801
Title: Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.
Journal: Journal of neuroimmunology 20030701
Title: Glatiramer acetate treatment in Devic's neuromyelitis optica.
Journal: Brain : a journal of neurology 20030601
Title: Predictors of adherence to glatiramer acetate therapy in individuals with self-reported progressive forms of multiple sclerosis.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20030601
Title: Management of multiple sclerosis: current trials and future options.
Journal: Current opinion in neurology 20030601
Title: Current disease-modifying therapies in multiple sclerosis.
Journal: Seminars in neurology 20030601
Title: Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis.
Journal: Neuropediatrics 20030601
Title: [Diagnosis and treatment of multiple sclerosis. Update, 2003].
Journal: MMW Fortschritte der Medizin 20030526
Title: Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20030501
Title: Glatiramer acetate (Copaxone) therapy for multiple sclerosis.
Journal: Pharmacology & therapeutics 20030501
Title: Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis.
Journal: Journal of neuroimmunology 20030401
Title: Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.
Journal: BMJ (Clinical research ed.) 20030308
Title: In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis.
Journal: Clinical immunology (Orlando, Fla.) 20030301
Title: A case of relapsing neuromyelitis optica treated with glatiramer acetate.
Journal: Journal of neurology 20030301
Title: Interferon beta-1a in primary progressive multiple sclerosis.
Journal: Journal of the neurological sciences 20030215
Title: Effects of polyclonal immunoglobulins and other immunomodulatory agents on microglial phagocytosis of apoptotic inflammatory T-cells.
Journal: Journal of neuroimmunology 20030201
Title: Interferon gamma and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment.
Journal: Journal of neurology, neurosurgery, and psychiatry 20030101
Title: Treatment of multiple sclerosis and related disorders: what's new in the past 2 years?
Journal: Clinical neuropharmacology 20030101
Title: Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosis.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20030101
Title: [Cost-utility analisys of multiple sclerosis treatment with glatiramer acetate or interferon beta in Spain].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20030101
Title: Early intervention in multiple sclerosis : better outcomes for patients and society?
Journal: Drugs 20030101
Title: [Glatiramer acetate (Copaxone) influence on different stages of multiple sclerosis pathogenesis].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101
Title: [Use of glatiramer acetate (Copaxone) in the treatment of patients with multiple sclerosis. Experience of the Moscow multiple sclerosis center].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101
Title: Induction of apoptosis of CD4+ T cells by immunomodulatory therapy of multiple sclerosis with glatiramer acetate.
Journal: European neurology 20030101
Title: Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers.
Journal: Polish journal of pharmacology 20030101
Title: Immunomodulation by the copolymer glatiramer acetate.
Journal: Journal of molecular recognition : JMR 20030101
Title: Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20021201
Title: A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis.
Journal: Clinical therapeutics 20021201
Title: Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses.
Journal: Neurology 20021112
Title: Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.
Journal: Brain : a journal of neurology 20021101
Title: Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects.
Journal: Internal medicine journal 20021101
Title: Immunological assay for assessing the efficacy of glatiramer acetate (Copaxone) in multiple sclerosis. A pilot study.
Journal: Journal of neurology 20021101
Title: Seizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta-1a and clomipramine.
Journal: Pharmacotherapy 20021101
Title: Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review.
Journal: Archives of internal medicine 20021028
Title: Copaxone's effect on MRI-monitored disease in relapsing MS is reproducible and sustained.
Journal: Neurology 20021022
Title: Partial and significant reversal of progressive visual and neurological deficits in multiple sclerosis: a possible therapeutic effect.
Journal: Clinical & experimental ophthalmology 20021001
Title: Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.
Journal: Neurology 20020924
Title: Key issues in the diagnosis and treatment of multiple sclerosis. An overview.
Journal: Neurology 20020924
Title: Sustained immunological effects of Glatiramer acetate in patients with multiple sclerosis treated for over 6 years.
Journal: Journal of the neurological sciences 20020915
Title: Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20020901
Title: Disease-modifying therapy in relapsing--remitting multiple sclerosis: efficacy is paramount.
Journal: International journal of clinical practice. Supplement 20020901
Title: Interferon beta but not glatiramer acetate therapy aggravates headaches in MS.
Journal: Neurology 20020827
Title: Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20020801
Title: Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20020801
Title: Immunomodulatory effects of glatiramer acetate on superantigen- and mitogen-induced T-cell stimulation in vitro.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20020801
Title: Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders.
Journal: Trends in molecular medicine 20020701
Title: Regional peptide uptake study in the rat intestinal mucosa: glatiramer acetate as a model drug.
Journal: Pharmaceutical research 20020601
Title: Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients: an open-label 2-year follow-up.
Journal: Journal of the neurological sciences 20020515
Title: Glatiramer acetate reduces the proportion of new MS lesions evolving into 'black holes'.
Journal: Neurology 20020514
Title: Oral treatment of mice with copolymer 1 (glatiramer acetate) results in the accumulation of specific Th2 cells in the central nervous system.
Journal: Journal of neuroimmunology 20020501
Title: Glatiramer acetate.
Journal: Neurologia (Barcelona, Spain) 20020501
Title: Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis.
Journal: Neurology 20020423
Title: Considerations in the treatment of relapsing-remitting multiple sclerosis.
Journal: Neurology 20020423
Title: Randomized controlled trials to assess therapies for multiple sclerosis.
Journal: Neurology 20020423
Title: Workshop on primary progressive multiple sclerosis: meeting summary.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20020401
Title: [Treatment of multiple sclerosis with glatiramer acetate. Current aspects of mechanisms of action, pharmacokinetics, adverse effect profile and clinical studies].
Journal: Der Nervenarzt 20020401
Title: Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
Journal: The Journal of clinical investigation 20020301
Title: Alphabet soup: a personal, evolving, mostly evidence-based and logical, sequential approach to the 'ABCNR' drugs in multiple sclerosis.
Journal: Seminars in neurology 20020301
Title: MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients.
Journal: Neurology 20020212
Title: Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients.
Journal: Journal of neuroimmunology 20020201
Title: Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines.
Journal: Neurology 20020122
Title: Multiple sclerosis.
Journal: Annual review of medicine 20020101
Title: Copolymer 1 (glatiramer acetate) in relapsing forms of multiple sclerosis: open multicenter study of alternate-day administration.
Journal: Clinical neuropharmacology 20020101
Title: Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.
Journal: CNS drugs 20020101
Title: Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis.
Journal: CNS drugs 20020101
Title: [Mechanisms of glatiramer acetate action in demyelinating diseases: antigen-specific, organ-specific or process-specific treatment].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20020101
Title: [Results of open post-registration clinical trials of copaxone in patients with multiple sclerosis].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20020101
Title: [Quality of life in multiple sclerosis and pharmaco-economic studies].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20020101
Title: Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis.
Journal: CNS drugs 20020101
Title: The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosis.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making 20020101
Title: Interleukin 12 and interleukin 10 are affected differentially by treatment of multiple sclerosis with glatiramer acetate (Copaxone).
Journal: Folia neuropathologica 20020101
Title: HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis.
Journal: Neurology 20011211
Title: Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis.
Journal: Journal of neuroimmunology 20011203
Title: A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing--remitting multiple sclerosis: results after 18 months of therapy.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20011201
Title: Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. 1998 [classical article].
Journal: Neurology 20011201
Title: [Recent therapeutic strategy for multiple sclerosis].
Journal: Rinsho shinkeigaku = Clinical neurology 20011201
Title: Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments.
Journal: Neurology 20011127
Title: Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).
Journal: Clinical and diagnostic laboratory immunology 20011101
Title: Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.
Journal: Acta neurologica Scandinavica 20011101
Title: Primary progressive multiple sclerosis.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20011101
Title: Predictors of adherence to Copaxone therapy in individuals with relapsing-remitting multiple sclerosis.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20011001
Title: Lipoatrophy associated with glatiramer acetate injections for the treatment of multiple sclerosis.
Journal: Cutis 20011001
Title: [New approaches in research of therapy of multiple sclerosis].
Journal: Medizinische Klinik (Munich, Germany : 1983) 20010915
Title: Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells.
Journal: Journal of neuroimmunology 20010903
Title: Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications.
Journal: Brain : a journal of neurology 20010901
Title: Glatiramer acetate reduces the proportion of new MS lesions evolving into 'black holes'.
Journal: Neurology 20010828
Title: Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20010801
Title: Glatiramer acetate in the treatment of multiple sclerosis.
Journal: Expert opinion on pharmacotherapy 20010701
Title: Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment.
Journal: Current opinion in neurology 20010601
Title: Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells.
Journal: Journal of neurochemistry 20010601
Title: Glatiramer acetate for multiple sclerosis.
Journal: Drug and therapeutics bulletin 20010601
Title: Immunologic therapy for relapsing-remitting multiple sclerosis.
Journal: Current neurology and neuroscience reports 20010501
Title: Immunologic therapy for secondary and primary progressive multiple sclerosis.
Journal: Current neurology and neuroscience reports 20010501
Title: Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone.
Journal: Journal of neuroimmunology 20010402
Title: Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells.
Journal: Brain : a journal of neurology 20010401
Title: Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness.
Journal: Expert opinion on pharmacotherapy 20010401
Title: Mechanisms of action of glatiramer acetate in multiple sclerosis.
Journal: Neurology 20010327
Title: Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate.
Journal: Journal of neurology, neurosurgery, and psychiatry 20010301
Title: European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.
Journal: Annals of neurology 20010301
Title: A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis.
Journal: European journal of neurology 20010301
Title: Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells.
Journal: Brain research. Molecular brain research 20010219
Title: [Escalating immunomodulatory therapy of multiple sclerosis. 1st supplement: December 2000].
Journal: Der Nervenarzt 20010201
Title: United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20010201
Title: Long-term therapy with glatiramer acetate in multiple sclerosis: effect on T-cells.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20010201
Title: Multiple sclerosis treatment 2001.
Journal: Neurologic clinics 20010201
Title: Immunotherapy of inflammatory demyelinating diseases of the central nervous system.
Journal: Immunologic research 20010101
Title: Glatiramer acetate (Copaxone).
Journal: International journal of clinical practice 20010101
Title: [Pathogenesis and treatment of multiple sclerosis (state of the art in 2000)].
Journal: Vestnik Rossiiskoi akademii meditsinskikh nauk 20010101
Title: [Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis].
Journal: Medicina 20010101
Title: Risk-benefit assessment of glatiramer acetate in multiple sclerosis.
Journal: Drug safety 20010101
Title: McKeage K. Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review. CNS Drugs. 2015;29(5):425-432.
Title: Arnon R, et al. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc Natl Acad Sci U S A. 2004;101 Suppl 2(Suppl 2):14593-14598.
Title: Corey-Bloom J, et al. Beneficial effects of glatiramer acetate in Huntington's disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms. Brain Res. 2017;1673:102-110.
Title: Aharoni R, et al. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ [published correction appears in Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12288 Proc Natl Acad Sci U S A. 2003;100(24):14157-14162.
